InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by DEPTULA-HICKS DARLENE M, Chief Financial Officer. Director active across 1 company, notably F-star Therapeutics, Inc.. In total, 3 disclosures have been logged. History available since 20 November 2020. The latest transaction was filed on 8 March 2023 (U). Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations
Darlene M. Deptula-Hicks is the Chief Financial Officer and Treasurer of F-star Therapeutics, Inc. She oversees the financial operations and funding strategy of the company, contributing to its growth and stability.